Viewing Study NCT00693966


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-16 @ 4:09 PM
Study NCT ID: NCT00693966
Status: COMPLETED
Last Update Posted: 2016-09-16
First Post: 2008-06-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infections, Papillomavirus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HPV, Vaccine View